Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma

Cancer specific inhibitors reflective of unique metabolic needs, are rare. We describe a novel small molecule, Gboxin, that specifically inhibits primary mouse and human glioblastoma (GBM) cell growth but not mouse embryo fibroblasts or neonatal astrocytes. Gboxin rapidly and irreversibly compromise...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yufeng, Lim, S. Kyun, Liang, Qiren, Iyer, Swathi V., Wang, Hua-Yu, Wang, Zilai, Xie, Xuanhua, Sun, Daochun, Chen, Yu-Jung, Tabar, Viviane, Gutin, Philip, Williams, Noelle, De Brabander, Jef K., Parada, Luis F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655586/
https://www.ncbi.nlm.nih.gov/pubmed/30842654
http://dx.doi.org/10.1038/s41586-019-0993-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655586/
https://www.ncbi.nlm.nih.gov/pubmed/30842654
http://dx.doi.org/10.1038/s41586-019-0993-x

Ejemplares similares